Literature DB >> 17511681

Patient and graft survival implications of simultaneous pancreas kidney transplantation from old donors.

P R Salvalaggio1, M A Schnitzler, K C Abbott, D C Brennan, W Irish, S K Takemoto, D Axelrod, L S Santos, B Kocak, L Willoughby, K L Lentine.   

Abstract

We investigated graft and patient survival implications of simultaneous pancreas kidney (SPK) transplant from old donors. Data describing patients with type 1 diabetes mellitus listed for an SPK transplant from 1994 to 2005 were drawn from Organ Procurement and Transplant Network registries. Allograft survival, patient survival and long-term survival expectations among SPK recipients from young (age <45 years) and old (age >/=45 years) donors were modeled by multivariate regression. We also examined predictors of reduced early access to young donor transplants. Of 16 496 eligible SPK candidates, 8850 patients (53.6%) received an SPK transplant and 776 (8.8%) of these transplants were from old donors. Reasonable 5-year, death-censored kidney (77.8 %) and pancreas (71.3%) survivals were achieved with old donors. SPK transplantation from both young and old donors predicted lower mortality compared to continued waiting. An additional expected wait of 1.5 years for a young donor equalized long-term survival expectations to that achieved with use of old donors. Early allocation of young donor transplants declined in the more recent era and varied by region, candidate age, blood type and sensitization. We conclude that old SPK donors should be considered for patients with decreased access to young donor transplants. Prospective evaluation of this practice is needed.

Entities:  

Mesh:

Year:  2007        PMID: 17511681     DOI: 10.1111/j.1600-6143.2007.01818.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  12 in total

1.  Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation.

Authors:  Julio Pascual; Milagros D Samaniego; José R Torrealba; Jon S Odorico; Arjang Djamali; Yolanda T Becker; Barbara Voss; Glen E Leverson; Stuart J Knechtle; Hans W Sollinger; John D Pirsch
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

2.  Guidelines for the assessment and acceptance of potential brain-dead organ donors.

Authors:  Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

3.  Influence of donor- and recipient-specific factors on the postoperative course after combined pancreas-kidney transplantation.

Authors:  Peter Thomas Fellmer; Andreas Pascher; Andreas Kahl; Frank Ulrich; Katharina Lanzenberger; Konstanze Schnell; Sven Jonas; Stefan G Tullius; Peter Neuhaus; Johann Pratschke
Journal:  Langenbecks Arch Surg       Date:  2010-01       Impact factor: 3.445

4.  Pancreas transplantation: does age increase morbidity?

Authors:  Cheguevara Afaneh; Barrie S Rich; Meredith J Aull; Choli Hartono; David B Leeser; Sandip Kapur
Journal:  J Transplant       Date:  2011-06-04

5.  Access to Transplantation and Transplant Outcome Measures (ATTOM): study protocol of a UK wide, in-depth, prospective cohort analysis.

Authors:  Gabriel C Oniscu; Rommel Ravanan; Diana Wu; Andrea Gibbons; Bernadette Li; Charles Tomson; John L Forsythe; Clare Bradley; John Cairns; Christopher Dudley; Christopher J E Watson; Eleanor M Bolton; Heather Draper; Matthew Robb; Lisa Bradbury; Rishi Pruthi; Wendy Metcalfe; Damian Fogarty; Paul Roderick; J Andrew Bradley
Journal:  BMJ Open       Date:  2016-02-25       Impact factor: 2.692

6.  Donor Characteristics of Pancreas Transplantation in Australia and New Zealand: A Cohort Study 1984-2014.

Authors:  Xi Alex Peng; Patrick J Kelly; William R Mulley; Henry Pleass; Helen Pilmore; Angela C Webster
Journal:  Transplant Direct       Date:  2016-08-08

7.  Donor insulin therapy in intensive care predicts early outcomes after pancreas transplantation.

Authors:  Iestyn M Shapey; Angela Summers; Hussein Khambalia; Petros Yiannoullou; Catherine Fullwood; Neil A Hanley; Titus Augustine; Martin K Rutter; David van Dellen
Journal:  Diabetologia       Date:  2021-03-04       Impact factor: 10.122

8.  Extended pancreas donor program - the EXPAND study rationale and study protocol.

Authors:  Andrea Proneth; Andreas A Schnitzbauer; Florian Zeman; Johanna R Foerster; Ines Holub; Helmut Arbogast; Wolf O Bechstein; Thomas Becker; Carsten Dietz; Markus Guba; Michael Heise; Sven Jonas; Stephan Kersting; Jürgen Klempnauer; Steffen Manekeller; Volker Müller; Silvio Nadalin; Björn Nashan; Andreas Pascher; Falk Rauchfuss; Michael A Ströhlein; Peter Schemmer; Peter Schenker; Stefan Thorban; Thomas Vogel; Axel O Rahmel; Richard Viebahn; Bernhard Banas; Edward K Geissler; Hans J Schlitt; Stefan A Farkas
Journal:  Transplant Res       Date:  2013-07-01

Review 9.  The effects of donor age on organ transplants: A review and implications for aging research.

Authors:  Jose Carlos Dayoub; Franco Cortese; Andreja Anžič; Tjaša Grum; João Pedro de Magalhães
Journal:  Exp Gerontol       Date:  2018-06-20       Impact factor: 4.032

10.  Expanding pancreas donor pool by evaluation of unallocated organs after brain death: Study protocol clinical trial (SPIRIT Compliant).

Authors:  Yakup Kulu; Elias Khajeh; Omid Ghamarnejad; Mohammadsadegh Nikdad; Mohammadsadegh Sabagh; Sadeq Ali-Hasan-Al-Saegh; Silvio Nadalin; Markus Quante; Przemyslaw Pisarski; Bernd Jänigen; Christoph Reißfelder; Markus Mieth; Christian Morath; Benjamin Goeppert; Peter Schirmacher; Oliver Strobel; Thilo Hackert; Martin Zeier; Rainer Springel; Christina Schleicher; Markus W Büchler; Arianeb Mehrabi
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.